Loss of CCR7 Expression on CD56bright NK Cells Is Associated with a CD56dimCD16+ NK Cell-Like Phenotype and Correlates with HIV Viral Load

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Hong, Henoch S ^a,b   Ahmad, Fareed ^a   Eberhard, Johanna M ^a   Bhatnagar, Nupur ^a   Bollmann, Benjamin A ^a   Keudel, Phillip ^a   Ballmaier, Matthias ^a   Zielinska Skowronek, Margot ^a   Schmidt, Reinhold E ^a   Meyer Olson, Dirk ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD56 ANTIGEN; CHEMOKINE RECEPTOR CCR7;

ARTICLE; CCR7- CD56 BRIGHT NATURAL KILLER CELL; CD56 BRIGHT NATURAL KILLER CELL; CD56 DIM CD16+ NATURAL KILLER CELL; CD56- CD16+ NATURAL KILLER CELL; CELL COMPARTMENTALIZATION; CELL SUBPOPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOLYSIS; DEGRANULATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INNATE IMMUNITY; LYMPHOCYTE FUNCTION; MALE; NATURAL KILLER CELL; PATHOGENESIS; PHENOTYPE; PROTEIN EXPRESSION; VIRUS LOAD;

ADULT; ANTIGENS, CD56; APOPTOSIS; BIOLOGICAL MARKERS; FEMALE; GENE EXPRESSION REGULATION; HIV-1; HUMANS; KILLER CELLS, NATURAL; MALE; PHENOTYPE; RECEPTORS, CCR7; RECEPTORS, IGG; VIRAL LOAD;

EID: 84866561013     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044820     Document Type: Article

References (32)

1. Caligiuri MA, (2008) Human natural killer cells. Blood 112: 461-469.
2. Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, et al. (2011) Innate or adaptive immunity? The example of natural killer cells. Science 331: 44-49.
3. Cooper MA, Fehniger TA, Caligiuri MA, (2001) The biology of human natural killer-cell subsets. Trends Immunol 22: 633-640.
4. Poli A, Michel T, Theresine M, Andres E, Hentges F, et al. (2009) CD56bright natural killer (NK) cells: an important NK cell subset. Immunology 126: 458-465.
5. Yu J, Mao HC, Wei M, Hughes T, Zhang J, et al. (2010) CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets. Blood 115: 274-281.
6. Altfeld M, Goulder P, (2007) 'Unleashed' natural killers hinder HIV. Nat Genet 39: 708-710.
7. Alter G, Heckerman D, Schneidewind A, Fadda L, Kadie CM, et al. (2011) HIV-1 adaptation to NK-cell-mediated immune pressure. Nature 476: 96-100.
8. Fauci AS, Mavilio D, Kottilil S, (2005) NK cells in HIV infection: paradigm for protection or targets for ambush. Nat Rev Immunol 5: 835-843.
9. Hong HS, Eberhard JM, Keudel P, Bollmann BA, Ballmaier M, et al. (2010) HIV infection is associated with a preferential decline in less-differentiated CD56dim CD16+ NK cells. J Virol 84: 1183-1188.
10. Mavilio D, Lombardo G, Benjamin J, Kim D, Follman D, et al. (2005) Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals. Proc Natl Acad Sci U S A 102: 2886-2891.
11. Alter G, Teigen N, Davis BT, Addo MM, Suscovich TJ, et al. (2005) Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection. Blood 106: 3366-3369.
12. Hong HS, Eberhard JM, Keudel P, Bollmann BA, Ahmad F, et al. (2010) Phenotypically and functionally distinct subsets contribute to the expansion of CD56-/CD16+ natural killer cells in HIV infection. Aids 24: 1823-1834.
13. Kottilil S, Jackson JO, Reitano KN, O'Shea MA, Roby G, et al. (2007) Innate immunity in HIV infection: enhanced susceptibility to CD95-mediated natural killer cell death and turnover induced by HIV viremia. J Acquir Immune Defic Syndr 46: 151-159.
14. Nagler A, Lanier LL, Cwirla S, Phillips JH, (1989) Comparative studies of human FcRIII-positive and negative natural killer cells. J Immunol 143: 3183-3191.
15. Freud AG, Becknell B, Roychowdhury S, Mao HC, Ferketich AK, et al. (2005) A human CD34(+) subset resides in lymph nodes and differentiates into CD56bright natural killer cells. Immunity 22: 295-304.
16. Chan A, Hong DL, Atzberger A, Kollnberger S, Filer AD, et al. (2007) CD56bright human NK cells differentiate into CD56dim cells: role of contact with peripheral fibroblasts. J Immunol 179: 89-94.
17. Romagnani C, Juelke K, Falco M, Morandi B, D'Agostino A, et al. (2007) CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation. J Immunol 178: 4947-4955.
18. Beziat V, Descours B, Parizot C, Debre P, Vieillard V, (2010) NK cell terminal differentiation: correlated stepwise decrease of NKG2A and acquisition of KIRs. PLoS ONE 5: e11966.
19. Beziat V, Duffy D, Quoc SN, Le Garff-Tavernier M, Decocq J, et al. (2011) CD56brightCD16+ NK cells: a functional intermediate stage of NK cell differentiation. J Immunol 186: 6753-6761.
20. Eller MA, Eller LA, Ouma BJ, Thelian D, Gonzalez VD, et al. (2009) Elevated natural killer cell activity despite altered functional and phenotypic profile in Ugandans with HIV-1 clade A or clade D infection. J Acquir Immune Defic Syndr 51: 380-389.
21. Meyer-Olson D, Brady KW, Bartman MT, O'Sullivan KM, Simons BC, et al. (2006) Fluctuations of functionally distinct CD8+ T-cell clonotypes demonstrate flexibility of the HIV-specific TCR repertoire. Blood 107: 2373-2383.
22. Hong HS, Bhatnagar N, Ballmaier M, Schubert U, Henklein P, et al. (2009) Exogenous HIV-1 Vpr disrupts IFN-alpha response by plasmacytoid dendritic cells (pDCs) and subsequent pDC/NK interplay. Immunol Lett 125: 100-104.
23. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A, (1999) Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401: 708-712.
24. Juelke K, Killig M, Luetke-Eversloh M, Parente E, Gruen J, et al. (2010) CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells. Blood 116: 1299-1307.
25. Mirandola P, Ponti C, Gobbi G, Sponzilli I, Vaccarezza M, et al. (2004) Activated human NK and CD8+ T cells express both TNF-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors but are resistant to TRAIL-mediated cytotoxicity. Blood 104: 2418-2424.
26. Alter G, Malenfant JM, Altfeld M, (2004) CD107a as a functional marker for the identification of natural killer cell activity. J Immunol Methods 294: 15-22.
27. Penack O, Gentilini C, Fischer L, Asemissen AM, Scheibenbogen C, et al. (2005) CD56dimCD16neg cells are responsible for natural cytotoxicity against tumor targets. Leukemia 19: 835-840.
28. Reeves RK, Gillis J, Wong FE, Yu Y, Connole M, et al. (2010) CD16- natural killer cells: enrichment in mucosal and secondary lymphoid tissues and altered function during chronic SIV infection. Blood 115: 4439-4446.
29. Reeves RK, Evans TI, Gillis J, Johnson RP, (2010) Simian immunodeficiency virus infection induces expansion of alpha4beta7+ and cytotoxic CD56+ NK cells. J Virol 84: 8959-8963.
30. Douek DC, Roederer M, Koup RA, (2009) Emerging concepts in the immunopathogenesis of AIDS. Annu Rev Med 60: 471-484.
31. Virgin HW, Wherry EJ, Ahmed R, (2009) Redefining chronic viral infection. Cell 138: 30-50.
32. Rehermann B, Nascimbeni M, (2005) Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 5: 215-229.